Cargando…
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
BACKGROUND: Increased breast cancer screening over the past four decades has led to a substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions precede invasive ductal carcinoma (IDC), they do not always transform into cancer. The current standard-of-care for DCIS i...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557595/ https://www.ncbi.nlm.nih.gov/pubmed/34717732 http://dx.doi.org/10.1186/s13058-021-01479-8 |